The rationale and indications for angiotensin receptor blockers in heart failure

Heart Fail Clin. 2006 Jan;2(1):81-8. doi: 10.1016/j.hfc.2005.11.003.

Authors

Kevin A Bybee¹, Sajal Das, James H O'Keefe

Affiliation

¹ Mid America Heart Institute, Kansas City, MO 64111, USA.

PMID: 17386879
DOI: 10.1016/j.hfc.2005.11.003

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Aged
Aged, 80 and over
Angiotensin II Type 1 Receptor Blockers / adverse effects
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Heart Failure / diagnosis
Heart Failure / drug therapy*
Heart Failure / mortality
Humans
Male
Middle Aged
Prognosis
Randomized Controlled Trials as Topic
Risk Assessment
Severity of Illness Index
Survival Analysis
Treatment Outcome

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors